Retinoic Acid Receptor beta Antibody | Rockland Immunochemicals 209-301-E26 product information

product summary

company name :

Rockland Immunochemicals

product type :

antibody

product name :

Retinoic Acid Receptor beta Antibody

catalog :

209-301-E26

quantity :

100 µL

clonality :

monoclonal

host :

mouse

conjugate :

nonconjugated

clone name :

336

reactivity :

human, rat

application :

western blot

more info or order :

Rockland Immunochemicals product webpage

product information

Catalog Number :

209-301-E26

Name :

Anti-Retinoic Acid Receptor beta (Mouse) Monoclonal Antibody - 209-301-E26

Display Name :

Retinoic Acid Receptor beta Antibody

Application Note :

Anti-Retinoic Acid Receptor beta antibody is suitable for use in Western Blotting to detect a single band at approximately 48 kDa corresponding to expected molecular weight for RAR-β proteins in the appropriate cell lysate or extract. Researchers should determine optimal titers for applications that are not stated below.

Buffer :

0.01 M HEPES, 0.15 M Sodium Chloride, pH 7.5

Clonality :

Monoclonal

Clone ID :

336

Concentration Value :

Titrated value sufficient to run approximately 10 mini blots.

Conjugation :

(None)

Size :

100 µL

Default Unit :

Western Blot Dilution :

1:1000

Expiration :

Expiration date is one (1) year from date of opening.

Format :

IgG1

Gene Name :

RARB

Host Animal :

Mouse

General Disclaimer Note :

This product is for research use only and is not intended for therapeutic or diagnostic applications. Please contact a technical service representative for more information. All products of animal origin manufactured by Rockland Immunochemicals are derived from starting materials of North American origin. Collection was performed in United States Department of Agriculture (USDA) inspected facilities and all materials have been inspected and certified to be free of disease and suitable for exportation. All properties listed are typical characteristics and are not specifications. All suggestions and data are offered in good faith but without guarantee as conditions and methods of use of our products are beyond our control. All claims must be made within 30 days following the date of delivery. The prospective user must determine the suitability of our materials before adopting them on a commercial scale. Suggested uses of our products are not recommendations to use our products in violation of any patent or as a license under any patent of Rockland Immunochemicals, Inc. If you require a commercial license to use this material and do not have one, then return this material, unopened to: Rockland Inc., P.O. BOX 5199, Limerick, Pennsylvania, USA.

Immunogen :

Anti-Retinoic Acid Receptor beta was produced by repeated immunizations with a synthetic peptide corresponding to amino acid residues from the N-terminal region of RAR beta.

Packing Type :

Dry Ice

Physical State :

Liquid

Purity and Specificity :

Anti-Retinoic Acid Receptor beta antibody detects Retinoic Acid Receptor beta. Retinoic Acid Receptor beta antibodies was Protein G purified from cell culture supernatant. This antibody is directed against human retinoic acid receptor beta protein. Expect reactivity with RAR beta from the following species is prediceted based on 100% sequence homology: canine, guinea pig, mouse, rat, non-human primate. Cross reactivity from other sources has not been determined.

Species Reactivity :

human, rat

Stabilizer :

0.1 mg/ml Bovine Serum Albumin (BSA) - IgG and Protease free, 50% (v/v) Glycerol

Storage :

Store vial at -20° C prior to opening. This product is stable at 4° C as an undiluted liquid. For extended storage, aliquot contents and freeze at -20° C or below. Avoid cycles of freezing and thawing. Dilute only prior to immediate use.

Subclass :

IgG1

Synonyms :

mouse anti-Retinoic Acid Receptor beta Antibody, mouse anti-RAR-beta antibody, HBV-activated protein, Nuclear receptor subfamily 1 group B member 2, RAR-epsilon

Target Species :

Human

Background :

Retinoic Acid Receptor beta antibody detects RAR beta. Retinoic Acid (RA; active metabolite of vitamin A) plays a prominent role in regulating the transition of proliferating precursor cells (such as carcinoma cells and neuronal precursors) to postmitotic differentiated cells. The Retinoid X receptors (RXRs) family (RXRα, β and γ) preferentially bind 9-cis-RA and regulate gene transcription by forming heterodimers with a second family of RA receptors (RARs). RAs have been suggested to potentially play a therapeutic role in cervical cancer. RAs are known to play key roles in neuronal development and an increasing body of evidence indicates that retinoid signaling may regulate synaptic plasticity and associated learning and memory behaviors.

Immunogen Type :

Peptide

Low Endotoxin :

Sample Size :

Target Domain of Reactivity :

N-Terminus

Application Text :

Western Blot,

Category :

Primary Antibodies

Conjugation Name :

Unconjugated

UniProt :

P10826

Primary Image Name :

Western blot of Anti-Retinoic Acid Receptor beta (Mouse) Antibody - 209-301-E26

more info or order :

Rockland Immunochemicals product webpage